Time filter

Source Type

Zhao B.,Heilongjiang Key Laboratory of Anti fibrosis Biotherapy | Li L.,Heilongjiang Key Laboratory of Anti fibrosis Biotherapy | Liu J.,Heilongjiang Key Laboratory of Anti fibrosis Biotherapy | Li H.,Heilongjiang Key Laboratory of Anti fibrosis Biotherapy | And 6 more authors.
PLoS ONE | Year: 2014

Background: Perfluorooctane sulfonate (PFOS) is a synthetic material that has been widely used in industrial applications for decades. Exposure to PFOS has been associated with decreased adult testosterone level, and Leydig cell impairment during the time of adulthood. However, little is known about PFOS effects in utero on fetal Leydig cells (FLC). Methods and Results: The present study investigated effects of PFOS on FLC function. Pregnant Sprague Dawley female rats received vehicle (0.05% Tween20) or PFOS (5, 20 mg/kg) by oral gavage from gestational day (GD) 11-19. At GD20, testosterone (T) production, FLC numbers and ultrastructure, testicular gene and protein expression levels were examined. The results indicate that exposures to PFOS have affected FLC function as evidenced by decreased T production, impaired FLC, reduced FLC number, and decreased steroidogenic capacity and cholesterol level in utero. Conclusion: The present study shows that PFOS is an endocrine disruptor of male reproductive system as it causes reduction of T production and impairment of rat fetal Leydig cells. © 2014 Zhao et al. Source

Discover hidden collaborations